Terapeutic Effect of Low Molecular Weight Heparin Combined with Ulinastatin on Acute Pancreatitis
谭向龙,王世斌,姚咏明,焦华波,李基业,费阳,吴晓松
DOI: https://doi.org/10.3969/j.issn.1673-6966.2008.10.009
2008-01-01
Abstract:Objective To evaluate the therapeutic effect of low molecular weight heparin (LMWH) combined with ulinastatin (UTI) on acute pancreatitis (AP). Methods One hundred age, and sex-matched AP patients were randomly divided into four equal groups: Group A (control group), Group B undergoing subcutaneous injection of LMWH 5000 U every 12 h, Group C undergoing intravenous drip of UTI 100 000 U every 8 h, and Group D undergoing both LMWH+UTI as described above. On days 1, 3, and 7 of the therapeutic course, WBC count and PaO2 were tested. The curative days, aggravation rates, operation rates, and mortality rates were also compared. Results On day 1, treatment with LMWH decreased the WBC counts. On days 3 and 7, treatment with LMWH, UTI reduced the WBC counts alone, and there was synergistic reaction between LMWH and UTI. On days 3 and 7, LMWH, UTI could elevate the PaO2 alone, and there was synergistic reaction between LMWH and UTI. LMWH, UTI decreased the curative days alone, but there was no synergistic reaction between LMWH and UTI. Conclusion LMWH combined with UTI to cure the AP can improve PaO2, decrease WBC counts and curative days.